NEW
YORK, Sept. 26, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Agenus
Inc. (NASDAQ: AGEN).
Shareholders who purchased shares of AGEN during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/agenus-loss-submission-form/?id=105028&from=4
CLASS PERIOD: January 23,
2023 to July 17, 2024
ALLEGATIONS: The complaint alleges that during the
class period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (i) the combination
therapy of their immuno-oncology products, botensilimab and
balstilimab was less effective than the defendants had led
investors to believe; (ii) accordingly, botensilimab and
balstilimab's clinical results, as well as their regulatory and
commercial prospects, were overstated; and (iii) as a result, the
Company's public statements were materially false and misleading at
all relevant times.
DEADLINE: November 5, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/agenus-loss-submission-form/?id=105028&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of AGEN during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is November 5, 2024. There is no cost
or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross
Law Firm is committed to ensuring that companies adhere to
responsible business practices and engage in good corporate
citizenship. The firm seeks recovery on behalf of investors who
incurred losses when false and/or misleading statements or the
omission of material information by a company lead to artificial
inflation of the company's stock. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/agen-lawsuit-alert-the-gross-law-firm-notifies-agenus-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302258949.html
SOURCE The Gross Law Firm